Alcohol Septal Ablation of Hyperthropic Obstructive Cardiomyopathy Patient with Respiratory Failure
Abstract
Hypertrophic Obstructive Cardiomyopathy (HOCM) prevalence is about 1 among 500 population. It is caused by genetic malformation. Dyspnoe, angina pectoris and syncope are clinical manisfestation. Pharmacological and non-pharmacological treatments can be performed to relieve the obstructive symptoms. Recently alcohol septal ablation has been proven improve haemodynamic and functional status.We report a case of HOCM patient with refractory lung oedema and intubated due to respiratory failure that was immediatelly improved afterseptal ablation.
Downloads
Download data is not yet available.
References
Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. Oct 27 1998;98(17):1750-1755.
Frank MJ, Abdulla AM, Canedo MI, Saylors RE. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol. Dec 1978;42(6):993-1001.
Robbins RC, Stinson EB. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. Mar 1996;111(3):586-594.
Braunwald E. Braunwald’s Heart Disease. In: Maron BJ, ed. Hyperthrophic Cardiomyopathy. Vol 2. 9 ed. philadelphia: Elsevier Saunders; 2012.
Sato Y, Taniguchi R, Nagai K, et al. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart. Jun 2003;89(6):659-660.
Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. Nov 5 2003;42(9):1687-1713.
Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. Apr 11 2006;113(14):1807-1816.
Yuniadi Y, Koencoro AS, Hanafy DA, Firman D, Soesanto AM, Segewiss H. Percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic cardiomyopathy: Indonesian initial experience. Med J Indones. 2009;19:164-71.
Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. Dec 2001;38(7):1994-2000.
Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. Nov 15 2001;38(6):1701-1706.
van Dockum WG, Beek AM, ten Cate FJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. May 17 2005;111(19):2503-2508.
Frank MJ, Abdulla AM, Canedo MI, Saylors RE. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol. Dec 1978;42(6):993-1001.
Robbins RC, Stinson EB. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. Mar 1996;111(3):586-594.
Braunwald E. Braunwald’s Heart Disease. In: Maron BJ, ed. Hyperthrophic Cardiomyopathy. Vol 2. 9 ed. philadelphia: Elsevier Saunders; 2012.
Sato Y, Taniguchi R, Nagai K, et al. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart. Jun 2003;89(6):659-660.
Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. Nov 5 2003;42(9):1687-1713.
Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. Apr 11 2006;113(14):1807-1816.
Yuniadi Y, Koencoro AS, Hanafy DA, Firman D, Soesanto AM, Segewiss H. Percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic cardiomyopathy: Indonesian initial experience. Med J Indones. 2009;19:164-71.
Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. Dec 2001;38(7):1994-2000.
Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. Nov 15 2001;38(6):1701-1706.
van Dockum WG, Beek AM, ten Cate FJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. May 17 2005;111(19):2503-2508.
Published
2013-10-16
Views & Downloads
Abstract views: 3692
PDF downloads: 9059
PDF downloads: 9059
How to Cite
Endang, J., Haryadi, H., Suridanda, S., S, A., Christian, R., Irmalita, I., Raharjo, S., & Yuniadi, Y. (2013). Alcohol Septal Ablation of Hyperthropic Obstructive Cardiomyopathy Patient with Respiratory Failure. Indonesian Journal of Cardiology, 34(1), 35-42. https://doi.org/10.30701/ijc.v34i1.304
Section
Case Reports
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
